Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26189394 | 1.00 | CYP2C19 (0.40) | CYP2C19CYP19A1 | |
| SCHEMBL13588477 | 1.00 | CYP2C19 (0.40) | CYP2C19CYP19A1 | |
| SCHEMBL26189395 | 0.85 | CYP2C19 (0.35) | CYP2C19 | |
| SCHEMBL21473304 | 0.83 | CYP2C19 (0.36) | CYP2C19 | |
| SCHEMBL13588474 | 0.77 | CYP19A1 (0.36) | CYP19A1 | |
| SCHEMBL21473201 | 0.75 | CYP2C19 (0.32) | CYP2C19 | |
| SCHEMBL21473200 | 0.75 | CYP2C19 (0.32) | CYP2C19 | |
| SCHEMBL22747925 | 0.75 | CYP2C19 (0.33) | CYP2C19 | |
| SCHEMBL29801495 | 0.75 | CYP2C19 (0.33) | CYP2C19 | |
| SCHEMBL22747923 | 0.75 | CYP2C19 (0.33) | CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11970473-B2 | Nootkatone derivatives and methods of using the same | Arkansas State University—Jonesboro (US) | 2024-04-30 | — | — | US | disclosed |
| US-20220324823-A1 | NOOTKATONE DERIVATIVES AND METHODS OF USING THE SAME | Arkansas State University - Jonesboro | 2022-10-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11970473-B2 | Nootkatone derivatives and methods of using the same | SDHA, PCK2, GOT2 | CYP2C19 1380/4885CYP19A1 521/4885 |
| US-20220324823-A1 | NOOTKATONE DERIVATIVES AND METHODS OF USING THE SAME | SDHA, PCK2, GOT2 | CYP2C19 1380/4885CYP19A1 521/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.